Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This study evaluates the safety and tolerability of TOP1288 rectal single and multiple
ascending doses in healthy subjects and multiple doses in subjects with ulcerative colitis.